paediatrics Brussels 17

POG

• 78 pts randomized to 35 Gy CSRT + 54 Gy PFRT +/- MOPP • Borderline difference in 5-year survival, favoring chemotherapy, 74% vs. 56%, (p = 0.06) • Pts > 5 yrs old, females and non-whites had the most benefit

Krischer JP et al. J Neurosurg 1991; 74:905-9